GGrantIndex
Sort

40,608 grants matching prostate cancer

Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease

$654,820
Matthew S Panizzon · University Of California, San Diego · R01 · FY2017 · AG

Georgia CaRes

$654,813
Sharad A. Ghamande · Augusta University · UG1 · FY2014 · CA

Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer

$654,763
Karen Sandell Sfanos · Johns Hopkins University · R01 · FY2024 · CA

Biospecimen procurement and tissue microarray manufacture for the CHTN

$654,719
Christopher A. Moskaluk · University Of Virginia · UM1 · FY2024 · CA

Research Program

$654,644
Alison Meredith Buttenheim · University Of Pennsylvania · P50 · FY2022 · CA

Enhancing the Efficacy of Docetaxel in Prostate Cancer

$654,537
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA

Genetic Epidemiology of Cancer

$654,515
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2014 · HG

Population Modeling of Bladder Cancer Detection and Control

$654,490
Thomas Trikalinos · Brown University · U01 · FY2022 · CA

MOLECULAR IMAGING AND THERAPY OF PROSTATE CANCER

$654,418
University Of Wisconsin System · · FY2011 · Department of Defense

Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy

$654,412
Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2023 · CA

Enhancing cancer outreach for low-income adults with innovative smoking cessation

$654,393
Alexander V Prokhorov · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA

Chemoprevention Clinical Trial of Pomegranate Fruit Extract in Men

$654,388
Kirk Weeks · University Of Wisconsin-Madison · N01 · FY2013 · CA

Etiologic Heterogeneity Between Molecular Subtypes of Prostate Cancer

$654,340
Konrad Hermann Stopsack · Massachusetts General Hospital · R37 · FY2024 · CA

Early Life Conditions, Survival, and Health: A Pedigree-Based Population Study

$654,307
Ken R Smith · University Of Utah · R01 · FY2015 · AG

Core 1

$654,206
Ann G Schwartz · Wayne State University · P01 · FY2025 · CA

ANTIBODY-FUNCTIONALIZED CARBON NANOTUBE TRANSISTORS AS BIOSENSORS FOR THE DETECTION OF PROSTATE CANCER

$654,173
Fox Chase Cancer Center · · FY2009 · Department of the Army

Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study

$654,143
Allison W. Kurian · Stanford University · R01 · FY2025 · CA

Modeling Precision Interventions for Prostate Cancer Control

$654,102
Ruth D Etzioni · Fred Hutchinson Cancer Center · U01 · FY2021 · CA

Optimizing Lung Cancer Screening in Cancer Survivors

$654,045
Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Application of MAGNet Tools to Gene Regulatory Networks in Cancer

$654,042
Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA

Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer

$654,000
Iwao Ojima · State University New York Stony Brook · R01 · FY2023 · CA

Protein kinase C and lung carcinogenesis

$653,908
Marcelo Gabriel Kazanietz · University Of Miami School Of Medicine · R01 · FY2025 · CA

Small Molecule ERG Inhibitors for Prostate Cancer

$653,897
John Hackett Bushweller · University Of Virginia · R01 · FY2024 · CA

Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer

$653,812
Hushan Yang · Thomas Jefferson University · R01 · FY2025 · CA

Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance

$653,723
Jiaoti Huang · Duke University · R01 · FY2025 · CA